KREJČÍ, Pavel, Kateřina PEJCHALOVÁ, B.E. ROSENBLOOM, F.P. ROSENFELT, E.L. TRAN, H. LAURELL and W.R. WILCOX. The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia. Journal of Leukocyte Biology. New York: Society for Leukocyte Biology, vol. 82, No 6, p. 1363-1364. ISSN 0741-5400. doi:10.1189/jlb.0607425. 2007.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, are up-regulated in B cell chronic lymphoid leukemia.
Authors KREJČÍ, Pavel (203 Czech Republic, guarantor, belonging to the institution), Kateřina PEJCHALOVÁ (203 Czech Republic), B.E. ROSENBLOOM (840 United States of America), F.P. ROSENFELT (840 United States of America), E.L. TRAN (840 United States of America), H. LAURELL (840 United States of America) and W.R. WILCOX (840 United States of America).
Edition Journal of Leukocyte Biology, New York, Society for Leukocyte Biology, 2007, 0741-5400.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30105 Physiology
Country of publisher United States of America
Confidentiality degree is not subject to a state or trade secret
Impact factor Impact factor: 4.128
RIV identification code RIV/00216224:14310/07:00067362
Organization unit Faculty of Science
Doi http://dx.doi.org/10.1189/jlb.0607425
UT WoS 000251243800001
Keywords in English FIBROBLAST-GROWTH-FACTOR; api5
Tags rivok, ZR
Changed by Changed by: prof. Ing. Petr Dvořák, CSc., učo 47260. Changed: 29/4/2014 09:40.
Abstract
The antiapoptotic protein Api5 and its partner, high molecular weight FGF2, were described to be up-regulated in B cell chronic lymphoid leukemia
Links
MSM0021622430, plan (intention)Name: Funkční a molekulární charakteristiky nádorových a normálních kmenových buněk - identifikace cílů pro nová terapeutika a terapeutické strategie
Investor: Ministry of Education, Youth and Sports of the CR, Functional and molecular characteristics of cancer and normal stem cells - identification of targets for novel therapeutics and therapeutic strategies
PrintDisplayed: 28/3/2024 21:51